Devi Thiagarajan, PhD, Postdoctoral Fellow
Devi Thiagarajan received her PhD from the Centre for DNA Fingerprinting and Diagnostics in India. Her thesis was titled “Epigenetic mechanisms underlying development: Role of Dnmt2 in RNA Processing”.
After specializing in epigenetic tools, she shifted her primary focus to cardiovascular complications. During her postdoctoral training at Wayne State University in Detroit, Michigan, she studied the implication of cytoskeleton organization in inducing inflammation using cell culture models.
Devi joined the Diabetes Research Program in December 2011. Working with Dr. Ravichandran Ramasamy, she studies the epigenetic modifications induced by aldose reductase and its toxic byproducts in ischemia-reperfusion as well as in hyperglycemic conditions.
1. Sowpati DT*, Thiagarajan D*, Sharma S, Sultana H, John R, Surani A, Mishra RK and Khosla S. An intronic DNA sequence within the mouse Neuronatin gene exhibits biochemical characteristics of an ICR and acts as a transcriptional activator in Drosophila. Mech. Dev. 2008, Nov-Dec; 125(11-12):963-73.
2. Thiagarajan D, Dev RR, Khosla S. The DNA methyltransferase Dnmt2 participates in RNA processing during cellular stress. Epigenetics. 2011. Jan; 103-13.
*- Joint first authors
News & Highlights
- Ravi Ramasamy, PhD was awarded a shared instrumentation grant from the National Institutes of Health for the acquisition of Seahorse system. <<more>>
- The Diabetes Research Program and NYU's Initiative in Data Science and Statistics were awarded a research grant from Independence Blue Cross. The goal of this collaboration is twofold; detect undiagnosed diabetes cases and predict potential cases of the disease. <<more>>
- Ann Marie Schmidt, MD and Ravi Ramasamy, PhD were awarded a grant from the NYU Abu Dhabi Institute. In collaboration with the NYU Abu Dhabi Public Health Research Institute, the project will examine the growing obesity and diabetes epidemic in Abu Dhabi.
- Ravi Ramasamy, PhD and Gabrielle Gold-von Simson, MD were awarded a multi-PI R25 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIH). " <<more>>
- More News & Highlights